Navigation Links
Spectral announces publication demonstrating Toraymyxin(TM) significantly reduces mortality from sepsis in prospective controlled trial
Date:6/18/2009

TORONTO, June 18 /PRNewswire-FirstCall/ - Spectral Diagnostics Inc. (TSX:SDI), a company developing products for the treatment of sepsis, today announced that findings demonstrating the Toraymyxin(TM) cartridge, a blood purification device that absorbs endotoxin from the bloodstream, when added to conventional therapy, significantly improved hemodynamics and organ dysfunction and reduced 28-day mortality in patients with severe sepsis and septic shock. The article entitled "Early Use of Polymyxin B Hemoperfusion in Abdominal Septic Shock: The EUPHAS Randomized Controlled Trial," was published in the Journal of the American Medical Association (JAMA). Spectral has exclusive rights to Toraymyxin(TM) in the United States and plans to initiate a trial in the U.S. in the latter half of 2009.

"The degree of reduction in mortality demonstrated by Toraymyxin(TM) in the EUPHAS trial is an unprecedented result for sepsis therapies and indicates that this product has the potential to fulfill an unmet need for the approximately 100,000 patients that develop severe sepsis or septic shock in the U.S. each year," said Dr. Paul Walker, President and CEO of Spectral Diagnostics. "Our Endotoxin Activity Assay (EAA(TM)) has the ability to identify patients who could benefit from this therapy and monitor its effect. Together, this diagnostic and therapeutic have the potential to provide a more effective treatment for patients with severe sepsis and septic shock caused by endotoxemia."

The objective of this study was to determine whether Toraymyxin(TM), when added to conventional medical therapy, improves clinical outcomes and mortality compared with conventional therapy alone, in a targeted patient population with severe sepsis and/or septic shock associated with intra-abdominal infections.

    -   28 day mortality was 32% (11/34 patients) in the Toraymyxin(TM) group
        and 53% (16/30 patients) in the conventional therapy group.
    - 
'/>"/>
SOURCE Spectral Diagnostics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Spectral announces first quarter 2009 results
2. Spectral announces presentations at the 29TH International Symposium on Intensive Care and Emergency Medicine focusing on the role of endotoxin
3. Spectral announces 2008 financial results
4. Spectral signs exclusive license agreement to bring sepsis therapeutic to the U.S. market
5. Surface plasmon resonances of metal nanoparticles in array can have narrower spectral widths
6. Spectral announces third quarter 2008 results
7. Spectral to bring anti-sepsis therapy to the U.S. market
8. Spectral announces exclusive distribution agreement in Russia for its EAA(TM) Sepsis Diagnostic Assay
9. Spectral announces continuing support for the combination of EAA(TM) and anti-endotoxin therapeutics
10. Spectral announces presentation of data on improving sepsis patient management with EAA(TM) and Toraymyxin(TM) combination
11. Spectral and Toray expand collaboration to include new geographic territories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... July 28, 2014 Research and Markets ... Analysis Market 2014-2018" report to their offering. ... analysis is a technique used to determine the size of ... It is crucial to analyze the size of particles as ... size analysis is performed to determine the behavior and nature ...
(Date:7/25/2014)... MA -- Trillions of bacteria live in each person,s ... help digest food and stave off harmful infections, but ... , To help shed light on the role of ... associate professor Eric Alm recently tracked fluctuations in the ... year. The findings, described in the July 25 issue ...
(Date:7/25/2014)... PA (PRWEB) July 25, 2014 The ... Call for Topics for Conferee Networking. These two-hour sessions ... interests to meet and resolve problems, discuss new techniques, ... The deadline to submit a topic for consideration is ... pittcon.org . The Conferee Networking committee will review ...
(Date:7/25/2014)... , July 25, 2014 Sinovac Biotech Ltd. (Nasdaq: ... in China , today announced that it ... ended June 30, 2014, after market close on Thursday, August ... prior to the market opening on Friday, August 15, 2014, ... p.m. China Standard Time) to review the Company,s financial results ...
Breaking Biology Technology:Global Particle Size Analysis Market 2014-2018 2Monitoring the rise and fall of the microbiome 2Monitoring the rise and fall of the microbiome 3Pittcon 2015 Announces Call for Topics for Conferee Networking Sessions 2Sinovac to Host Conference Call to Report Second Quarter 2014 Unaudited Financial Results 2
... Wisconsin governor are playing a game of one- upsmanship on pocketbook ... to up the ante after Gov. Jim Doyle announced ... ethanol. , ,Green, however, did not take that opportunity to call ... once voted for legislation to repeal the controversial law. Instead, he ...
... of the Fox Broadcasting Company 's hit television program, ... preparing to exploit a consumer market catering to aspiring pop ... products for digital video, music, DVD, and audio production, has ... develop two software products based on the show, which won ...
... Wis. - Saying former employees began to develop Bone ... that purchased Bone Care in 2005 is suing three former ... , , Genzyme Corp . filed the suit in ... , claiming that the plaintiffs applied for patents on new ...
Cached Biology Technology:Green doesnt up the ante on markup law 2American Idol spurs music software 2Genzyme sues former Bone Care employees 2Genzyme sues former Bone Care employees 3
(Date:7/25/2014)... been raging this summer and some of the smoke from ... this image collected by the Moderate Resolution Imaging Spectroradiometer (MODIS) ... of smoke has descended over the Great Lakes region of ... fire image from July 23, 2014 (first image feature highlighted ... drifts off southeastward. In the image, it is over ...
(Date:7/25/2014)... the International Journal of Cancer earlier this ... based on findings showing successful reduction in the risk ... of cells in the cervix. , The findings ... cells, or SCJ cells. These cells reside in the ... of cervical cancer. A research team co-led by Christopher ...
(Date:7/25/2014)... engineering at the University of Houston, has written ... organ development., "Introduction to Tissue Engineering: Applications and ... the field of artificial organ development. Metin Akay, ... UH, served as a series editor on the ... published books on the subject of growing artificial ...
Breaking Biology News(10 mins):Clearing cells to prevent cervical cancer 2University of Houston researcher publishes textbook on tissue engineering 2
... at the RIKEN SPring-8 Center in Harima, Japan have ... reductase (qNOR), a bacterial enzyme that offers clues on ... to their importance to fundamental science, the findings provide ... ozone-depleting and greenhouse gas hundreds of times more potent ...
... of alcohol found in alcoholic beverages, can more than double ... Caenorhabditis elegans , which is used frequently as a model ... find their discovery difficult to explain. "This ... UCLA professor of chemistry and biochemistry and the senior author ...
... electromagnetic Terahertz (THz) waves or T-rays - the technology behind ... in the journal Nature Photonics , say their new ... to make better medical scanning gadgets and may one day ... Star Trek. In the study, researchers from the Institute ...
Cached Biology News:New study sheds light on evolutionary origin of oxygen-based cellular respiration 2Tiny amounts of alcohol dramatically extend a worm's life, but why? 2Tiny amounts of alcohol dramatically extend a worm's life, but why? 3Tiny amounts of alcohol dramatically extend a worm's life, but why? 4T-rays technology could help develop Star Trek-style hand-held medical scanners 2T-rays technology could help develop Star Trek-style hand-held medical scanners 3
Anti-Potassium Channel EAG-1 Immunogen: Synthetic peptide from the C-terminus of rat Kv10.1 (Accession Q63472). The immunogen sequence is identical in mouse and 14/16 residues identical in human...
WIF-1 (N-20)...
VEGF Receptor-2, phospho-specific (Tyr996)...
For the differentiation of mouse embryonic stem cells tooligodendrocytes....
Biology Products: